We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

72 hedge funds and large institutions have $137M invested in ChemoCentryx, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 26 increasing their positions, 21 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

392% more call options, than puts

Call options by funds: $118K | Put options by funds: $24K

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

34% more capital invested

Capital invested by funds: $103M → $137M (+$34.9M)

24% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 21

6% less funds holding

Funds holding: 7772 (-5)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
72
Holders Change
-5
Holders Change %
-6.49%
% of All Funds
1.92%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
7
Increased
26
Reduced
21
Closed
11
Calls
$118K
Puts
$24K
Net Calls
+$94K
Net Calls Change
-$399K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of Montreal
76
Bank of Montreal
Ontario, Canada
-$144K -32,059 Closed
Susquehanna International Group
77
Susquehanna International Group
Pennsylvania
-$147K -31,052 Closed
Jane Street
78
Jane Street
New York
-$72K -16,035 Closed
MA
79
MUFG Americas
New York
-$7K -1,551 Closed
UBS Group
80
UBS Group
Switzerland
-$5.26K -1,114 -98%
TRCT
81
Tower Research Capital (TRC)
New York
-$3K -753 Closed
Simplex Trading
82
Simplex Trading
Illinois
-$3.31K -701 Closed
PNC Financial Services Group
83
PNC Financial Services Group
Pennsylvania
-$1K -166 Closed

CCXI Hedge Fund Activity: Q3 2016 in Review

72 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2016, worth a combined $137M — up 34% from $103M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of CCXI and 7 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 26 added.

The largest buyer was Artal Group, adding an estimated $1.42M. The largest seller was Oxford Asset Management, cutting an estimated $988K.

  • 72 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2016, down from 77 in Q2 2016.
  • Funds reported $137M of ChemoCentryx, Inc. stock for Q3 2016, up 34% quarter-over-quarter.
  • 7 funds opened new ChemoCentryx, Inc. positions in Q3 2016 and 11 closed out, a net change of -4 holders.
  • The largest ChemoCentryx, Inc. buyer in Q3 2016 was Artal Group, an estimated $1.42M added.
  • The largest ChemoCentryx, Inc. seller in Q3 2016 was Oxford Asset Management, an estimated $988K sold.

Based on aggregated 13F filings for Q3 2016.